-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $472

Benzinga·10/22/2026 15:49:38
Listen to the news
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $469 to $472.